Sugaru; Eiji
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sugaru; Eiji.The latest application filed is for "drug targeting cancer stem cell".
- Sugaru; Eiji - Osaka JP
- Sugaru; Eiji - Osaka-shi Osaka
| Patent | Date |
|---|---|
| Imidazolylamide derivative Grant 10,898,469 - Ban , et al. January 26, 2 | 2021-01-26 |
| Drug Targeting Cancer Stem Cell App 20200268728 - Fukunaga; Yuichi ; et al. | 2020-08-27 |
| Compositions for Treating and/or Preventing Cancer App 20200237711 - Li; Chiang Jia ; et al. | 2020-07-30 |
| Imidazolylamide Derivative App 20190060282 - Ban; Hitoshi ; et al. | 2019-02-28 |
| Novel blood sugar controller and method of screening the same App 20050119174 - Sugaru, Eiji ; et al. | 2005-06-02 |
| Remedies for anorexia or lifestyle-related diseases and method of screening the same App 20050019320 - Sugaru, Eiji ; et al. | 2005-01-27 |
| Remedies for life style-related diseases or cibophobia and method of screening the same App 20050014689 - Sugaru, Eiji ; et al. | 2005-01-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 